PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF LIVER DISEASE

摘要

The drug composition for prevention and treatment of liver diseases contains ursodesoxycholic acid and silimarine (the compsn. ratio is 1-3 wt. part(S): 1-5 wt. part(S)); or ursodesoxycholic acid and s-adenosyl-L-methionine-sulfate-p-toluene sulfonate (the compsn. ratio is 1-3 wt. part (S): 1-4 wt. part (S)). The compsn. contains pref. 50-100 mg of ursodesoxycholic acid and 70-140 mg of silimarine; or the compsn. contains pref. 50-100 mg of ursodesoxycholic acid and 96-288 mg of S-adenosyl-L-methionine-sulfate-P-toluene sulfonate.